1
|
Ji Q, Zhang L, Xu J, Ji P, Song M, Chen Y, Guo L. The relationship between stigma and quality of life in hospitalized middle-aged and elderly patients with chronic diseases: the mediating role of depression and the moderating role of psychological resilience. Front Psychiatry 2024; 15:1346881. [PMID: 38840950 PMCID: PMC11151782 DOI: 10.3389/fpsyt.2024.1346881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Accepted: 05/01/2024] [Indexed: 06/07/2024] Open
Abstract
Objective Patients with chronic diseases may have some psychological problems due to their own or surrounding environmental factors, which can adversely affect the patient's illness and life. Given that the number of chronically ill patients in China is currently increasing every year, more research is needed to determine the best ways to manage changes in psychological status and psychological stress responses in chronically ill patients. The researchers constructed a mediated moderation model to explore the impact of stigma on the quality of life of chronically ill patients, as well as the mediating role of depression and the moderating role of psychological resilience. Methods A stratified sampling method was used to select 363 middle-aged and old-aged patients with chronic diseases aged 45 years and older from the Affiliated Hospital of Zhejiang University for the study. Data were collected from patients with chronic diseases such as cardiac, respiratory, renal, and other chronic diseases using the Cumulative Illness Rating Scale for Geriatrics (CIRS-G), the Stigma Scale for Patients with Chronic Diseases (SSCI), the Patient Health Questionaire-9 (PHQ-9), the Quality of Life Inventory (SF-12), and the Conner-Davidson Resilience Scale (CD-RISC) were collected from patients with cardiac, respiratory, renal, and other chronic diseases. A descriptive analysis was used to describe the sample. Linear regression was used to evaluate the relationship between the variables. Mediation and moderation analyses were used to explore the mediating role of depression and the moderating role of psychological resilience. Results There was a moderate negative correlation between stigma and quality of life (r = -0.378, P < 0.01). There was a moderate negative correlation between depression and quality of life (r = -0.497, P < 0.01). There was a moderately positive correlation between psychological resilience and quality of life (r = 0.382, P < 0.01). There was a moderate negative correlation between psychological resilience and depression (r = -0.348, P < 0.01). There was a weak negative correlation between psychological resilience and stigma (r = -0.166, P < 0.01). There was a strong positive correlation between stigma and depression (r = 0.607, P < 0.01) The mediation study showed that stigma was a significant predictor of quality of life and that stigma and quality of life were mediated to some extent by depression, with the mediating effect accounting for 67.55% of the total effect. The direct path from stigma to depression is moderated by psychological resilience (β = -0.0018, P < 0.01). Conclusions Depression mediates the relationship between stigma and quality of life, while psychological elasticity plays a moderating role between stigma and depression, and when the level of psychological elasticity increases, the more significant the role of stigma on depression. As a physiologically and psychologically vulnerable group, patients with chronic diseases' overall quality of life and mental health should be taken more seriously, and clinical workers should pay timely attention to the psychological and mental conditions of patients with chronic diseases and provide timely and appropriate interventions and therapeutic measures. The relevant results of this study also provide a new perspective for clinical work on psychological intervention for patients with chronic diseases.
Collapse
Affiliation(s)
- Qiqi Ji
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| | - Lin Zhang
- Department of Internal Medicine Nursing, School of Nursing, Wannan Medical College, Wuhu, An Hui, China
| | - Jiashuang Xu
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| | - Pengjuan Ji
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| | - Miaojing Song
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| | - Yian Chen
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| | - Leilei Guo
- School of Nursing, Jinzhou Medical University, Jinzhou, Liaoning, China
| |
Collapse
|
2
|
Akdağ G, Canbaz Kabay S, Bican Demir A, Ergin Bakar E, Koç G, Üstün Özek S, Küçük A, Ünsal MA, Neyal A, Florentina Ateş M, Çelik HT, Kılıçparlar Cengiz E, Kutlu G, Ağırcan D, Karacan Gölen M, Bek S, Çınar N, Sahin S, Şişman Bayar AB, Terzi M, Kendirli Aslan S, Kenar SG, Kutluhan S, Ekmekyapar Fırat Y, Yılmaz Okuyan D, Bayar MD, Mert Atmaca M, Yalçın D, Genç F, Köse Leba L, Yılmaz B, Eren F, Bolu NE, Keskin Güler S, Akıncı T, Reyhani A, Yıldırım Sitembölükbaşı N, Türkmen N, Karşıdağ S, Velioğlu SK, Demir A, Haytı B, Hasırcı Bayır BR, Ezgi Uçan Tokuç F, Demir G, Çakmakçı G, Özkan H, Bulut O, Kesim Şahin Ö, Sürmeli R, Tekin S, Sarıoğlu ŞG, Gesoğlu Demir T, Akkoyun Arıkan F, Çetiner M. The effect of sleep disorders on quality of life in patients with epilepsy: A multicenter study from Turkey. Epilepsy Behav 2024; 150:109568. [PMID: 38141572 DOI: 10.1016/j.yebeh.2023.109568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 10/31/2023] [Accepted: 11/26/2023] [Indexed: 12/25/2023]
Abstract
OBJECTIVE We aimed to investigate sleep disorders in patients with epilepsy (PWE) and to investigate the effects of sleep disorders on quality of life. METHODS In our multicenter study conducted in Turkey, 1358 PWE were evaluated. The demographic and clinical data of the patients were recorded. The Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and Quality of Life in Epilepsy Inventory-10 (QOLIE-10) were administered. RESULTS The mean age of 1358 patients was 35.92 ± 14.11 (range, 18-89) years. Seven hundred fifty-one (55.30 %) were women. Some 12.7 % of the patients had insomnia (ISI > 14), 9.6 % had excessive daytime sleepiness (ESS > 10), 46.5 % had poor sleep quality (PSQI > 5), and 354 patients (26.1 %) had depressive symptoms (BDI > 16). The mean QOLIE-10 score was 22.82 ± 8.14 (10-48). Resistant epilepsy was evaluated as the parameter with the highest risk affecting quality of life Adjusted odds ratio (AOR = 3.714; 95 % confidence interval (CI): [2.440-5.652] < 0.001)). ISI (AOR = 1.184; 95 % CI: [1.128-1.243]; p < 0.001), ESS (AOR = 1.081; 95 % CI: [1.034-1.130]; p < 0.001), PSQI (AOR = 0.928; 95 % CI: [0.867 - 0.994]; p = 0.034), BDI (AOR = 1.106; 95 % CI: [1.084-1.129]; p < 0.001), epilepsy duration (AOR = 1.023; 95 % CI: [1.004-1.041]; p = 0.014), were determined as factors affecting quality of life. SIGNIFICANCE Sleep disorders are common in PWE and impair their quality of life. Quality of life can be improved by controlling the factors that may cause sleep disorders such as good seizure control, avoiding polypharmacy, and correcting the underlying mood disorders in patients with epilepsy.
Collapse
Affiliation(s)
- Gönül Akdağ
- Kutahya Health Sciences University, Faculty of Medicine, Department of Neurology, Kutahya, Türkiye.
| | - Sibel Canbaz Kabay
- Kutahya Health Sciences University, Faculty of Medicine, Department of Neurology, Kutahya, Türkiye.
| | - Aylin Bican Demir
- Uludağ University, Faculty of Medicine, Department of Neurology, Bursa, Türkiye.
| | - Ebru Ergin Bakar
- University of Health Sciences, Ankara Training and Research Hospital, Department of Neurology, Ankara, Türkiye.
| | - Güray Koç
- University of Health Sciences, Ankara City Hospital, Department of Neurology, Ankara, Türkiye
| | - Sibel Üstün Özek
- University of Health Sciences, Prof.Dr.Cemil Taşçıoğlu City Hospital, Department of Neurology, İstanbul, Türkiye.
| | - Ahmet Küçük
- University of Health Sciences, Konya Beyhekim Training and Research Hospital, Neurology Clinic, Konya, Türkiye.
| | - Miraç Ayşen Ünsal
- Sultan 2.Abdulhamid Khan Educational and Research Hospital, Department of Neurology, Istanbul, Türkiye.
| | - Abdurrahman Neyal
- Gaziantep Islam Science and Technology University School of Medicine, Department of Neurology, Gaziantep, Türkiye.
| | | | - Havva Tuğba Çelik
- Haydarpasa Numune Training and Research Hospital, İstanbul, Türkiye.
| | | | - Gülnihal Kutlu
- Muğla Sıtkı Koçman University, Faculty of Medicine, Department of Neurology, Muğla, Türkiye.
| | - Dilek Ağırcan
- Harran University, Faculty of Medicine, Department of Neurology, Sanlıurfa, Türkiye.
| | | | - Semai Bek
- Muğla Sıtkı Koçman University, Faculty of Medicine, Department of Neurology, Muğla, Türkiye.
| | - Nilgün Çınar
- Maltepe University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye.
| | - Sevki Sahin
- University of Health Sciences, Hamidiye Faculty of Medicine, Department of Neurology, Sancaktepe Sehit Prof. Dr. Ilhan Varank SUAM, Istanbul, Türkiye.
| | - Aysel Büşra Şişman Bayar
- Haseki Training and Research Hospital, University of Health Sciences, Department of Neurology, Istanbul, Türkiye.
| | - Murat Terzi
- Ondokuz Mayıs University, Faculty of Medicine, Department of Neurology, Samsun, Türkiye.
| | - Sude Kendirli Aslan
- Maltepe University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye.
| | - Safiye Gül Kenar
- Necmettin Erbakan University, Faculty of Medicine, Department of Neurology, Konya, Türkiye.
| | - Süleyman Kutluhan
- Süleyman Demirel University, Faculty of Medicine, Department of Neurology, Isparta, Türkiye.
| | | | | | - Muhammet Duran Bayar
- Gaziosmanpaşa Training and Research Hospital, University of Health Sciences, Department of Neurology, Istanbul, Türkiye.
| | - Murat Mert Atmaca
- Sultan 2.Abdulhamid Khan Educational and Research Hospital, Department of Neurology, Istanbul, Türkiye.
| | - Destina Yalçın
- Maltepe University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye.
| | - Fatma Genç
- University of Health Sciences Antalya Training and Research Hospital, Department of Neurology, Antalya, Türkiye.
| | - Leyla Köse Leba
- Necmettin Erbakan University, Faculty of Medicine, Department of Neurology, Konya, Türkiye.
| | - Buket Yılmaz
- SANKO University School of Medicine, Department of Neurology, Gaziantep, Türkiye.
| | - Fettah Eren
- Selçuk University, Faculty of Medicine, Department of Neurology, Konya, Türkiye.
| | - Naci Emre Bolu
- Maltepe University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye.
| | - Selda Keskin Güler
- University of Health Sciences, Ankara Training and Research Hospital, Department of Neurology, Ankara, Türkiye.
| | - Tuba Akıncı
- Haydarpasa Numune Training and Research Hospital, İstanbul, Türkiye.
| | - Aylin Reyhani
- Sultan 2.Abdulhamid Khan Educational and Research Hospital, Department of Neurology, Istanbul, Türkiye.
| | | | - Nur Türkmen
- Tekirdağ Dr İsmail Fehmi Cumalıoğlu City Hospital, Clinic of Clinical Neurophysiology, Tekirdağ, Türkiye.
| | - Sibel Karşıdağ
- Sultan 2.Abdulhamid Khan Educational and Research Hospital, Department of Neurology, Istanbul, Türkiye.
| | - Sibel K Velioğlu
- Karadeniz Technical University, Faculty of Medicine, Department of Neurology, Clinical Neurophysiology Unit, Trabzon, Türkiye.
| | | | - Barış Haytı
- Pamukkale University, School of Medicine, Department of Neurology, Denizli, Turkey.
| | | | - Firdevs Ezgi Uçan Tokuç
- University of Health Sciences Antalya Training and Research Hospital, Department of Neurology, Antalya, Türkiye
| | - Göksemin Demir
- Pamukkale University, School of Medicine, Department of Neurology, Denizli, Turkey.
| | - Güngör Çakmakçı
- Kutahya Health Sciences University, Faculty of Medicine, Department of Neurology, Kutahya, Türkiye.
| | - Hülya Özkan
- Trakya University, School of Medicine, Department of Neurology, Edirne, Türkiye.
| | | | - Özlem Kesim Şahin
- Haydarpasa Numune Training and Research Hospital, İstanbul, Türkiye.
| | - Reyhan Sürmeli
- Ümraniye Training and Research Hospital, Istanbul, Türkiye.
| | - Selma Tekin
- Pamukkale University, School of Medicine, Department of Neurology, Denizli, Turkey.
| | - Şerife Gizem Sarıoğlu
- Süleyman Demirel University, Faculty of Medicine, Department of Neurology, Isparta, Türkiye.
| | - Tülin Gesoğlu Demir
- Harran University, Faculty of Medicine, Department of Neurology, Sanlıurfa, Türkiye.
| | - Fatma Akkoyun Arıkan
- Kutahya Health Sciences University, Faculty of Medicine, Department of Neurology, Kutahya, Türkiye.
| | - Mustafa Çetiner
- Kutahya Health Sciences University, Faculty of Medicine, Department of Neurology, Kutahya, Türkiye.
| |
Collapse
|
3
|
Büyükbayram Z, Aksoy M, Yılmaz R. The effects of concealment of epilepsy on medication adherence in people with epilepsy: A cross-sectional study. Epilepsy Res 2023; 196:107220. [PMID: 37699282 DOI: 10.1016/j.eplepsyres.2023.107220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 08/26/2023] [Accepted: 08/30/2023] [Indexed: 09/14/2023]
Abstract
AIM Adherence to antiseizure medication is of great importance in achieving seizure control and maintaining well-being for people with epilepsy. Therefore, it is important to assess medication adherence and factors affecting medication adherence in this patient group. This study aims to examine the effects of concealment of epilepsy on medication adherence in people with epilepsy. METHOD This cross-sectional study was conducted with 220 people with epilepsy. Data were collected using a patient information form, the Morisky Medication Adherence Scale-8 (MMAS-8), and the Concealment of Epilepsy Scale (CES) and analyzed using descriptive statistics and multiple linear regression analysis. RESULTS The mean age of the participants was 49.84 ± 9.43 years, and 53.6% of them were male. Their mean MMAS-8 score was 4.25 ± 1.99%, and 72.3% had low medication adherence. Additionally, their mean CES score was 49.84 ± 9.43. The CES scores of the participants negatively predicted their MMAS-8 scores (p < 0.05), and medication adherence was positively predicted by female gender, the duration of diagnosis, the single administration of drugs per day, and employment status, whereas it was negatively predicted by the annual number of seizures (F=19.256, p < 0.001). CONCLUSION In this study, people with epilepsy were found to have low medication adherence and a high tendency to conceal epilepsy. Furthermore, the tendency to conceal epilepsy had a negative effect on medication adherence. IMPLICATIONS Psychosocial interventions aimed at reducing the tendency to conceal epilepsy can contribute to medication adherence in people with the condition.
Collapse
Affiliation(s)
- Zeliha Büyükbayram
- Siirt University, Faculty of Health Sciences, Department of Internal Medicine Nursing, Siirt, Turkey
| | - Meyreme Aksoy
- Siirt University, Faculty of Health Sciences, Department of Nursing Fundamentals, Siirt, Turkey.
| | - Rıdvan Yılmaz
- Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
| |
Collapse
|
4
|
Yang TW, Kim YS, Kim DH, Yeom JS, Kwon OY. Felt stigma proportion in people living with epilepsy: A systematic review. Seizure 2023; 111:87-97. [PMID: 37556985 DOI: 10.1016/j.seizure.2023.07.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Accepted: 07/31/2023] [Indexed: 08/11/2023] Open
Abstract
PURPOSE Numerous inventories to identify felt stigma (FS) in people living with epilepsy (PLWE) have been developed. Past studies have mainly focused on the relationship between FS scores and clinical factors, making it challenging to delineate FS proportions and compare FS between groups. We aimed to integrate FS proportions in PLWE and compare them by continent. METHODS We searched MEDLINE, EMBASE, the Cochrane Library, Web of Science, and Scopus. Among the identified studies, we chose the ones providing an FS proportion measured by Jacoby's Stigma Scale (JSS) and its revised version (JSS-R) in PLWE. We applied the random-effects model. RESULTS A total of 63 datasets from 47 studies were included. There were 29,924 PLWE, with 14,323 of them experiencing FS. The overall FS proportion was 48.4%. Of these datasets, 51 used JSS, and 12 used JSS-R. The FS proportions were 44.9% for the former and 62.1% for the latter, with significant heterogeneity. In the intercontinental comparison with 51 datasets employing JSS, the difference in FS proportions was insignificant: 51.2% in Africa, 47.2% in Europe, 35.4% in Asia, and 28.8% in the Middle East. Furthermore, the meta-regression revealed that the year of each primary study did not influence the FS proportion. CONCLUSION Among PLWE, FS proportions depended on the choice of a measurement tool. When measured using JSS, the FS proportion was 44.9%, while it was 62.1% when evaluated with JSS-R. Even though the FS proportions were integrated differently, no substantial differences were observed between continents.
Collapse
Affiliation(s)
- Tae-Won Yang
- Department of Neurology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Department of Neurology, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea
| | - Young-Soo Kim
- Department of Neurology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Department of Neurology, Gyeongsang National University Hospital, Jinju, Republic of Korea
| | - Do-Hyung Kim
- Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
| | - Jung Sook Yeom
- Department of Pediatrics, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Department of Pediatrics, Gyeongsang National University Hospital, Jinju, Republic of Korea
| | - Oh-Young Kwon
- Department of Neurology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea; Department of Neurology, Gyeongsang National University Hospital, Jinju, Republic of Korea; Institute of Medical Science, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
| |
Collapse
|
5
|
Joseph HB, Digal M, Benny A, Singh D, Vijayan L, Kaur S, Noshi T. Quality of life and its relation with sleep habits of children with epilepsy from Eastern India. JOURNAL OF EDUCATION AND HEALTH PROMOTION 2023; 12:200. [PMID: 37546002 PMCID: PMC10402785 DOI: 10.4103/jehp.jehp_985_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/09/2022] [Accepted: 12/01/2022] [Indexed: 08/08/2023]
Abstract
BACKGROUND Epilepsy is one of the most common chronic disorders of the central nervous system. The quality of life of children with epilepsy is influenced by various factors including their sleep. To assess the quality of life and sleep habits among children with epilepsy and to determine the association of QOL and sleep habits, with sociodemographic and clinical variables. MATERIALS AND METHODS A cross-sectional study was carried out among 50 epileptic children aged 4-18 years, recruited using a convenient sampling technique from the IPDs and OPDs of the Paediatrics department of a tertiary care hospital in Eastern India. The data were collected using QOLCE-16 and CSHQ from parents of children with epilepsy. The collected data were analyzed using descriptive and inferential statistics such as ANOVA and Pearson correlation test. RESULTS The overall mean score of QOL was 50.78 ± 17.98, with the cognitive domain having the highest mean score of 65.50 ± 27.79 and the social domain having the lowest mean score of 29.87 ± 22.81. The overall mean sleep score was found to be 56.98 ± 8.13. Daytime sleepiness, parasomnias, and bedtime resistance were found to be frequent sleep problems in children with epilepsy. There was a significant negative correlation between QOL and sleep disturbances in children with epilepsy (r = -0.65, P ≤ 0.001). CONCLUSION The QOL of children with epilepsy should be improved to reduce the effect of sleep problems. Epilepsy children should be treated appropriately with due focus on medication compliance as it was found to be one of the determinants in improving their QOL.
Collapse
Affiliation(s)
- Hepsi Bai Joseph
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Malini Digal
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Anna Benny
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Dolly Singh
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Lakshmi Vijayan
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Sukhsimran Kaur
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| | - Tumyir Noshi
- College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
| |
Collapse
|
6
|
Muacevic A, Adler JR. Quality of Life in Adult Patients With Epilepsy in Lebanon: A Cross-Sectional Study. Cureus 2022; 14:e30254. [PMID: 36381842 PMCID: PMC9652779 DOI: 10.7759/cureus.30254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2022] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND Epilepsy is a chronic and heterogeneous neurological disorder that impairs the quality of life (QOL) of sufferers and affects their mental health in many aspects. Few studies have been conducted in the Middle East, especially in Lebanon, on the QOL of patients with epilepsy. The aim of our study is to assess the burden of epilepsy on the life of adult patients in Lebanon and measure the impact of sociodemographic and clinical factors on the QOL. MATERIALS AND METHODS A total of 47 patients from several neurology clinics were included in our study and asked to fill out a questionnaire including the sociodemographic variables and epilepsy-related factors. We used the Quality of Life in Epilepsy Scale-31 (QOLIE-31), which is a 31-question form covering seven attributes of the QOL; overall QOL, emotional wellbeing, social functioning, cognition, energy, seizure worry and medication effects, to assess the QOL of adult patients with epilepsy. Analysis was conducted using SPSS program version 23. RESULTS The mean age of our sample was 37.54 years, 53.2% of which were males. The majority were unemployed, educated, and belonging to the medium socioeconomic level. The highest subscale score was for the social functioning subscale with a mean of 74.49±25.89 and the lowest subscale score was for seizure worry with a mean of 55.81±27.14. Employment status, nationality, and socioeconomic level were shown to be associated with the QOL scores. There were no correlations between the clinical factors and the QOL scores. CONCLUSION Sociodemographic factors, namely Lebanese nationality, employment status, and socioeconomic level, were associated with better QOL, reflected by the significant associations between the following parameters and the QOL scores (p-value<0.05), highlighting the positive influence of social support on the outcome of the disease. However, epilepsy-related clinical features did not show any correlation with the QOL and its subscales.
Collapse
|
7
|
Vergonjeanne M, Auditeau E, Thébaut C, Boumediene F, Preux PM. Instruments for investigation of epilepsy in low- and middle-income countries: a systematic review. Epilepsy Res 2022; 180:106865. [DOI: 10.1016/j.eplepsyres.2022.106865] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2021] [Revised: 12/13/2021] [Accepted: 01/17/2022] [Indexed: 01/07/2023]
|
8
|
Zhang H, Zhong R, Chen Q, Guo X, Han Y, Zhang X, Lin W. Depression severity mediates the impact of perceived stigma on quality of life in patients with epilepsy. Epilepsy Behav 2021; 125:108448. [PMID: 34839245 DOI: 10.1016/j.yebeh.2021.108448] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2021] [Revised: 11/11/2021] [Accepted: 11/12/2021] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To determine whether and the extent to which depression severity mediates the impact of perceived stigma on quality of life in patients with epilepsy (PWE). METHODS A consecutive cohort of 165 PWE was invited to participate in this study. Each participant completed the Kilifi Stigma Scale of Epilepsy (KSSE), Depression Inventory for Epilepsy (NDDI-E), and Quality of Life in Epilepsy Inventory (QOLIE-31). Mediation analysis was employed to assess whether depression severity mediates the relationship between perceived stigma and quality of life. RESULTS Perceived stigma was positively associated with depression severity and negatively associated with quality of life in PWE. The mediation analysis confirmed that perceived stigma had an indirect effect on the quality of life through the mediating variable of depression severity in PWE (B = -0.576, SE = 0.097, Bootstrap95% CI = -0.784 to -0.405). The indirect effects of perceived stigma on quality of life through depression severity accounted for 57.7% of the total effects of perceived stigma on quality of life. CONCLUSION This study provided evidence that depression severity mediates the impact that perceived stigma has on quality of life, indicating that assessment of and interventions targeting depression may be appropriate for PWE.
Collapse
Affiliation(s)
- Hanyu Zhang
- Department of Neurology, The First Hospital of Jilin University, Changchun, China
| | - Rui Zhong
- Department of Neurology, The First Hospital of Jilin University, Changchun, China
| | - Qingling Chen
- Department of Hepatology, Second People's Clinical Colleague of Tianjin Medical University, Tianjin, China
| | - Xin Guo
- Department of Neurology, The First Hospital of Jilin University, Changchun, China
| | - Yujian Han
- Department of Neurology, The First Hospital of Jilin University, Changchun, China
| | - Xinyue Zhang
- Department of Neurology, The First Hospital of Jilin University, Changchun, China
| | - Weihong Lin
- Department of Neurology, The First Hospital of Jilin University, Changchun, China.
| |
Collapse
|
9
|
Lee SA. Felt stigma in seizure-free persons with epilepsy: Associated factors and its impact on health-related quality of life. Epilepsy Behav 2021; 122:108186. [PMID: 34252827 DOI: 10.1016/j.yebeh.2021.108186] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 06/15/2021] [Accepted: 06/20/2021] [Indexed: 11/28/2022]
Abstract
PURPOSE We investigated felt stigma in seizure-free persons with epilepsy with regard to associated factors and its impact on health-related quality of life (HRQoL). METHODS This cross-sectional study included 81 patients who had been seizure free for at least 2 years and 52 controls who had only had one seizure in the last 2 years. All patients completed the Stigma Scale, Quality of Life in Epilepsy Inventory-31 (QOLIE-31), short form of the Eysenck Personality Questionnaire-Revised (EPQ-RS), Hospital Anxiety Depression Scale (HADS), Rosenberg Self-esteem Scale, and the enacted stigma questionnaire. RESULTS The proportion of felt stigma was not significantly different between controls (25%) and patients in seizure remission (21%). A stepwise logistic regression analysis revealed that enacted stigma and higher EPQ-RS Neuroticism scores were more likely to be associated with felt stigma of patients in remission. Quality of Life in Epilepsy Inventory-31 scores were significantly higher in patients in seizure remission than in controls. In the stepwise linear regression analysis, felt stigma was not associated with the total QOILE-31 scores. Sobel tests showed that felt stigma had indirect effects on the QOLIE-31 scores through EPQ-RS Neuroticism scores, but its statistical significance was lost after controlling for the presence of enacted stigma, anxiety, and depressive symptoms. CONCLUSION One-fifth of seizure-free patients continued to feel stigmatized, even though they had not had a seizure in more than 2 years. Experience of enacted stigma and a neurotic personality trait were the most important correlates of felt stigma for these patients. Health-related quality of life was significantly better in patients in remission than in patients with rare seizures. Felt stigma was not a significant or independent factor associated with worse HRQoL in patients in remission.
Collapse
Affiliation(s)
- Sang-Ahm Lee
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
| | -
- Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
10
|
Srikanth P, Vranda MN, Thomas PT, Raghvendra K. Quality of Life and Stigma among Women with Epilepsy during Their Reproductive Years. J Epilepsy Res 2021; 11:63-71. [PMID: 34395225 PMCID: PMC8357557 DOI: 10.14581/jer.21009] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Revised: 06/18/2021] [Accepted: 06/22/2021] [Indexed: 11/16/2022] Open
Abstract
Background and Purpose The purpose of this study was to understand the relationship between quality of life and stigma among reproductive age group women with epilepsy. Methods A cross-sectional descriptive study was conducted to assess the data from the 49 women with epilepsy from a tertiary care hospital in India. Quality of life was evaluated with the quality of life in epilepsy-31 questionnaire and stigma was evaluated with the stigma scale of epilepsy. Data also included socio-demographic and clinical characteristics. Results The mean age of the participants was 24.67±3.72 years. Quality of life total score (r=−0.485**) and seizure worry domain (r=−0.427**) were significantly negatively correlated with stigma total score at p<0.01 level. Being uneducated, married, unemployed, having children, having generalized tonic-clonic seizures, duration of illness (>10 years), and consuming levetiracetam, anti-epileptic drug (AED), were the significant contributing factors for low quality of life among women with epilepsy during the reproductive age group. Belonging to lower socio-economic status and taking more than two AEDs were also associated with lower quality of life among women with epilepsy, which are trending towards significance. Conclusions The study assessed the relationship between the quality of life and the Stigma scale of epilepsy and demonstrated the impact of stigma and quality of life on socio-demographic and clinical variables of women with epilepsy under the reproductive age group. To enhance the quality of life and reduce the stigma levels among women with epilepsy, some of the modifiable parameters can be considered by the multidisciplinary health care professionals from the findings of the current research.
Collapse
|